When Guidelines Aren’t Good Enough: Data That Demands Access to Genetic Testing | Dr. Ed Esplin

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare

For decades, genetic testing was rationed, reserved only for patients who fit narrow, outdated clinical guidelines. But what happens when those guidelines leave countless people at risk? In this episode, clinical geneticist and medical innovator Dr. Ed Esplin of LabCorp Genetics reveals how his team’s groundbreaking research exposed the flaws in restrictive testing policies. Through rigorous studies in breast cancer, colorectal cancer, and beyond, they proved that universal germline genetic testing identifies far more at-risk patients than guidelines ever predicted and fundamentally changes how we treat and prevent disease.

Th ...